BTG4 is A Novel P53 Target Gene That Inhibits Cell Growth and Induces Apoptosis

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2020 Feb 26

PMID 32093041

Citations 7

Authors

Na Zhang

Tinghui Jiang

Yitao Wang

Sen Wang

Lanyue Hu

Youquan Bu

Affiliations

Soon will be listed here.

Abstract

BTG4 is the last cloned and poorly studied member of BTG/Tob family. Studies have suggested that BTG4 is critical for the degradation of maternal mRNAs in mice during the process of maternal-to-zygotic transition, and downregulated in cancers, such as gastric cancer. However, the regulatory mechanism of BTG4 and its function in cancers remain elusive. In this study, we have for the first time identified the promoter region of the human BTG4 gene. Serial luciferase reporter assay demonstrated that the core promoter of BTG4 is mainly located within the 388 bp region near its transcription initiation site. Transcription factor binding site analysis revealed that the BTG4 promoter contains binding sites for canonical transcription factors, such as Sp1, whereas its first intron contains two overlapped consensus p53 binding sites. However, overexpression of Sp1 has negligible effects on BTG4 promoter activity, and site-directed mutagenesis assay further suggested that Sp1 is not a critical transcription factor for the transcriptional regulation of BTG4. Of note, luciferase assay revealed that one of the intronic p53 binding sites is highly responsive to p53. Both exogenous p53 overexpression and adriamycin-mediated endogenous p53 activation result in the transcriptional upregulation of BTG4. In addition, BTG4 is downregulated in lung and colorectal cancers, and overexpression of BTG4 inhibits cell growth and induces apoptosis in cancer cells. Taken together, our results strongly suggest that BTG4 is a novel p53-regulated gene and probably functions as a tumor suppressor in lung and colorectal cancers.

Citing Articles

A pan-cancer analysis of anti-proliferative protein family genes for therapeutic targets in cancer.

Zhang S, Gu J, Shi L, Qian B, Diao X, Jiang X Sci Rep. 2023; 13(1):21607.

PMID: 38062199 PMC: 10703880. DOI: 10.1038/s41598-023-48961-1.

PHLDA1 is a P53 target gene involved in P53-mediated cell apoptosis.

Song X, Zhou L, Yang W, Li X, Ma J, Qi K Mol Cell Biochem. 2023; 479(3):653-664.

PMID: 37155089 DOI: 10.1007/s11010-023-04752-w.

Cell cycle dysregulation with overexpression of KIF2C/MCAK is a critical event in nasopharyngeal carcinoma.

Zuo X, Meng P, Bao Y, Tao C, Wang Y, Liu X Genes Dis. 2023; 10(1):212-227.

PMID: 37013060 PMC: 10066047. DOI: 10.1016/j.gendis.2021.05.003.

Diepoxybutane induces the p53-dependent transactivation of the CCL4 gene that mediates apoptosis in exposed human lymphoblasts.

Ewunkem A, Deve M, Harrison S, Muganda P J Biochem Mol Toxicol. 2023; 37(5):e23316.

PMID: 36775894 PMC: 10175094. DOI: 10.1002/jbt.23316.

Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair.

Blanchet A, Bourgmayer A, Kurtz J, Mellitzer G, Gaiddon C Cancers (Basel). 2021; 13(4).

PMID: 33671606 PMC: 7926742. DOI: 10.3390/cancers13040916.

References

Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y . Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008; 68(11):4123-32. DOI: 10.1158/0008-5472.CAN-08-0325. View

Liu Y, Lu X, Shi J, Yu X, Zhang X, Zhu K . BTG4 is a key regulator for maternal mRNA clearance during mouse early embryogenesis. J Mol Cell Biol. 2016; 8(4):366-8. DOI: 10.1093/jmcb/mjw023. View

Auer R, Starczynski J, McElwaine S, Bertoni F, Newland A, Fegan C . Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2005; 43(1):1-10. DOI: 10.1002/gcc.20159. View

Yuniati L, Scheijen B, Van der Meer L, van Leeuwen F . Tumor suppressors BTG1 and BTG2: Beyond growth control. J Cell Physiol. 2018; 234(5):5379-5389. PMC: 6587536. DOI: 10.1002/jcp.27407. View

Wang Y, Zhang C, Jin Y, Wang , He Q, Liu Z . Alkaline ceramidase 2 is a novel direct target of p53 and induces autophagy and apoptosis through ROS generation. Sci Rep. 2017; 7:44573. PMC: 5353723. DOI: 10.1038/srep44573. View

Busson M, Carazo A, Seyer P, Grandemange S, Casas F, Pessemesse L . Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. Oncogene. 2005; 24(10):1698-710. DOI: 10.1038/sj.onc.1208373. View

Buanne P, Corrente G, Micheli L, Palena A, Lavia P, Spadafora C . Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics. 2000; 68(3):253-63. DOI: 10.1006/geno.2000.6288. View

Dong W, Tu S, Xie J, Sun P, Wu Y, Wang L . Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer. Biochem Biophys Res Commun. 2009; 387(1):132-8. DOI: 10.1016/j.bbrc.2009.06.140. View

Hu L, Chen Q, Wang Y, Zhang N, Meng P, Liu T . Sp1 Mediates the Constitutive Expression and Repression of the PDSS2 Gene in Lung Cancer Cells. Genes (Basel). 2019; 10(12). PMC: 6947312. DOI: 10.3390/genes10120977. View

10.

Lv C, Wang H, Tong Y, Yin H, Wang D, Yan Z . The function of BTG3 in colorectal cancer cells and its possible signaling pathway. J Cancer Res Clin Oncol. 2017; 144(2):295-308. PMC: 5794823. DOI: 10.1007/s00432-017-2561-9. View

11.

Majid S, Dar A, Ahmad A, Hirata H, Kawakami K, Shahryari V . BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009; 30(4):662-70. PMC: 2664457. DOI: 10.1093/carcin/bgp042. View

12.

Yoneda M, Suzuki T, Nakamura T, Ajima R, Yoshida Y, Kakuta S . Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma. Cancer Sci. 2008; 100(2):225-32. PMC: 11159387. DOI: 10.1111/j.1349-7006.2008.01030.x. View

13.

Sakai T, Hino K, Wada S, Maeda H . Identification of the DNA binding specificity of the human ZNF219 protein and its function as a transcriptional repressor. DNA Res. 2003; 10(4):155-65. DOI: 10.1093/dnares/10.4.155. View

14.

Hermeking H . The miR-34 family in cancer and apoptosis. Cell Death Differ. 2009; 17(2):193-9. DOI: 10.1038/cdd.2009.56. View

15.

Boiko A, Porteous S, Razorenova O, Krivokrysenko V, Williams B, Gudkov A . A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev. 2006; 20(2):236-52. PMC: 1356114. DOI: 10.1101/gad.1372606. View

16.

Liu W, Wang H, Muguira M, Breslin M, Lan M . INSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylases. Biochem J. 2006; 397(1):169-77. PMC: 1479746. DOI: 10.1042/BJ20051669. View

17.

Ji Y, Xie M, Lan H, Zhang Y, Long Y, Weng H . PRR11 is a novel gene implicated in cell cycle progression and lung cancer. Int J Biochem Cell Biol. 2012; 45(3):645-56. DOI: 10.1016/j.biocel.2012.12.002. View

18.

Wang Y, Zhang Y, Zhang C, Weng H, Li Y, Cai W . The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development. Biochim Biophys Acta. 2015; 1849(9):1133-44. DOI: 10.1016/j.bbagrm.2015.07.002. View

19.

Gou D, Wang J, Gao L, Sun Y, Peng X, Huang J . Identification and functional analysis of a novel human KRAB/C2H2 zinc finger gene ZNF300. Biochim Biophys Acta. 2004; 1676(2):203-9. DOI: 10.1016/j.bbaexp.2003.11.011. View

20.

Yoshida Y, Nakamura T, Komoda M, Satoh H, Suzuki T, Tsuzuku J . Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev. 2003; 17(10):1201-6. PMC: 196063. DOI: 10.1101/gad.1088003. View